Altos Labs

Altos Labs is a biotechnology company dedicated to cell rejuvenation aimed at reversing disease, injury, and age-related disabilities. Founded in 2022 and based in Redwood City, California, the company combines academic research with industry innovation to develop transformative medicines. With an initial funding of $3 billion, Altos operates multiple research facilities across the United States, United Kingdom, and Japan. The company's mission focuses on restoring cell health and resilience through advanced cellular reprogramming technology. Altos Labs emphasizes understanding epigenetic pathways to combat aging and disease, with research initiatives centered on human cell aging and DNA methylation mechanisms. Their work includes developing cell rejuvenation therapies, drug-development pipelines, and computational biology applications to enhance the understanding of biological systems. Altos Labs primarily serves the healthcare and biomedicine sectors, aiming to create medicines that address age-related conditions throughout the human lifespan.